KYMR Kymera Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
13:13
Jun 21
Jun 21
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A.
KYMR
Kymera Therapeutics, Inc.
Long
1ST
—
—
15:03
Jan 24
Jan 24
Degrader science overvalued; KYMR caution
The author mentions his earlier KYMR short call ($100 to about $70) and says the market and big pharma always overvalue degrader science. This suggests a cautious, negative view of KYMR's valuation, but he makes no explicit new short call and also treats KYMR as a strong competitor. He does not disclose a position.
KYMR
Kymera Therapeutics, Inc.
Avoid
—
—
10:47
Jan 11
Jan 11
r/StockMarket
Elliott Wave fifth wave long after gap fill above $80.
Author asserts KYMR is setting up for a fifth Elliott Wave advance after a gap-fill fourth-wave pullback. The trade triggers on an entry through $80 with a stop at $66.92 and a target of $114, giving a stated reward/risk of 2.6. The technical catalysts cited are completed Elliott Wave 4 rules, an Elliott Wave Oscillator pullback between 90% and 140%, and a stochastic cross in oversold territory.
KYMR
Kymera Therapeutics, Inc.
Long
1ST
—
—
About KYMR Investor Commentary
Across the available history and selected sources, Buzzberg tracks KYMR (Kymera Therapeutics, Inc.) across 3 sources: 2 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 8% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 25 total trade ideas tracked. Past 7 days, before deduplication: 5 other directions. Latest voices: seedy19tron, u/PaulxBrat.